Latest news
Aclarion, Inc. Revenue Breakdown – LS:A412BH - TradingViewTradingView · Fri, 07 Aug 2026 17:47:32 GMTAclarion, Inc. (ACON) 10-Q Q2 2026: Financial Results, Stock Updates, and Key SEC Filings - MinichartMinichart · Thu, 06 Aug 2026 21:19:00 GMTAclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - BitgetBitget · Thu, 06 Aug 2026 15:36:24 GMTAclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:11:00 GMTAclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock TitanStock Titan · Thu, 06 Aug 2026 13:01:17 GMTAclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20 - Strong Buy Stocks - dars.gov.etdars.gov.et · Tue, 04 Aug 2026 15:40:35 GMTAclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:15:00 GMTAclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMT